Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Black

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
International Journal of Dermatology|May 5, 2005
Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosisLeslie Baumann, Anele Slezinger, Monica Halem, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 22, 2005
Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosisLeslie Baumann, Anele Slezinger, Monica Halem, et al.
Cutis|September 8, 2005
Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoagingLeslie Baumann, Justin Vujevich, Monica Halem, et al.
European Journal of Clinical Pharmacology|April 6, 2012
Vorapaxar, an oral PAR-1 receptor antagonist, does not affect the pharmacokinetics and pharmacodynamics of warfarinTeddy Kosoglou, Yali Zhu, Fengjuan Xuan, et al.
The Lancet. Respiratory Medicine|March 26, 2026
Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort studyKiran Reddy, Pratik Sinha, David B Antcliffe, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Journal of Dermatology|May 5, 2005
Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosisLeslie Baumann, Anele Slezinger, Monica Halem, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 22, 2005
Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosisLeslie Baumann, Anele Slezinger, Monica Halem, et al.
Cutis|September 8, 2005
Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoagingLeslie Baumann, Justin Vujevich, Monica Halem, et al.
European Journal of Clinical Pharmacology|April 6, 2012
Vorapaxar, an oral PAR-1 receptor antagonist, does not affect the pharmacokinetics and pharmacodynamics of warfarinTeddy Kosoglou, Yali Zhu, Fengjuan Xuan, et al.
The Lancet. Respiratory Medicine|March 26, 2026
Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort studyKiran Reddy, Pratik Sinha, David B Antcliffe, et al.
Pageof 2